These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26234887)

  • 1. Cumulative genetic risk and age at onset in Parkinson's disease.
    Pihlstrøm L; Toft M
    Mov Disord; 2015 Oct; 30(12):1712-3. PubMed ID: 26234887
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Parkinson's disease risk loci on age at onset.
    Lill CM; Hansen J; Olsen JH; Binder H; Ritz B; Bertram L
    Mov Disord; 2015 May; 30(6):847-50. PubMed ID: 25914293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNCA: major genetic modifier of age at onset of Parkinson's disease.
    Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
    Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
    Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
    Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk and age in Parkinson's disease: Continuum not stratum.
    Nalls MA; Escott-Price V; Williams NM; Lubbe S; Keller MF; Morris HR; Singleton AB;
    Mov Disord; 2015 May; 30(6):850-4. PubMed ID: 25778492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.
    Chen S; Zhang Y; Chen W; Wang Y; Liu J; Rong TY; Ma JF; Wang G; Zhang J; Pan J; Xiao Q; Chen SD
    Neurosci Lett; 2012 May; 516(1):21-3. PubMed ID: 22465138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients.
    Guimarães Bde C; Pereira AC; Rodrigues Fda C; dos Santos AV; Campos M; dos Santos JM; dos Santos FL; de Rosso AL; Nicaretta DH; Pereira JS; da Silva DJ; Della Coletta MV; Santos-Rebouças CB; Pimentel MM
    Parkinsonism Relat Disord; 2012 Jun; 18(5):688-9. PubMed ID: 22192918
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
    Liu H; Han X; Li Y; Zou H; Xie A
    Neurosci Lett; 2013 Jun; 546():42-5. PubMed ID: 23648388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
    von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
    BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
    Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
    Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
    Peplonska B; Safranow K; Gaweda-Walerych K; Maruszak A; Czyzewski K; Rudzinska M; Barcikowska M; Zekanowski C
    Neurobiol Aging; 2013 Aug; 34(8):2078.e1-2. PubMed ID: 23522842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease.
    Groen JL; Kawarai T; Toulina A; Rivoiro C; Salehi-Rad S; Sato C; Morgan A; Liang Y; Postuma RB; St George-Hyslop P; Lang AE; Rogaeva E
    Neurosci Lett; 2004 Dec; 372(3):226-9. PubMed ID: 15542245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the oxidative polymorphism and early onset of Parkinson's disease.
    Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
    Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.
    Ribner A; Altarescu G; Zimran A; Elstein D
    Mov Disord; 2011 Jun; 26(7):1341-3. PubMed ID: 21469198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor PITX3 gene in Parkinson's disease.
    Le W; Nguyen D; Lin XW; Rawal P; Huang M; Ding Y; Xie W; Deng H; Jankovic J
    Neurobiol Aging; 2011 Apr; 32(4):750-3. PubMed ID: 19394114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease.
    Hua P; Liu W; Zhao Y; Ding H; Wang L; Xiao H
    Sleep Med; 2012 Mar; 13(3):297-300. PubMed ID: 22257907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.
    Haghnejad L; Emamalizadeh B; Jamshidi J; Bidoki AZ; Ghaedi H; Ahmadi E; Abdollahi S; Shahmohammadibeni N; Taghavi S; Fazeli A; Motallebi M; Zarneh AE; Mohammadihosseinabad S; Abbaszadegan MR; Torkamandi S; Gavenaroudi MA; Pedram N; Shahidi GA; Tafakhori A; Darvish H; Movafagh A
    J Neurol Sci; 2015 Aug; 355(1-2):72-4. PubMed ID: 26070653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.